ALKS Stock Analysis: Buy, Sell, or Hold?
ALKS - Alkermes Inc. plc
$48.33
0.31 (0.65%)
▲
5d:
-1.49%
30d:
-8.76%
90d:
+30.8%
HOLD
MODERATE Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Jul 28, 2026
0d
Get Alerted When ALKS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ALKS trades at premium valuation expecting 6.6% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: ALKS trades at premium valuation expecting 6.6% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$77.61
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$48.19
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ALKS is currently trading at $48.33, which is considered oversold relative to its 30-day fair value range of $48.96 to $52.07. From a valuation perspective, the stock is trading at a premium (Forward PE: 26.4) compared to its historical average (21.8). At these levels, the market is pricing in 6.6% annual earnings growth.
Technical Outlook: Technically, ALKS is in a strong uptrend. The price is currently testing key support at $47.33. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $56.00 (+15.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ALKS is in a strong uptrend. The price is currently testing key support at $47.33. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $56.00 (+15.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$48.96 -
$52.07
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.5%
Protect Your Profits
Holding ALKS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (49/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($56.00)
- BULLISH: Expecting earnings turnaround to 6.6% growth with 27.0% revenue growth
- NEUTRAL: Bottoming setup forming (49/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$48.96 -
$52.07
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$47.33
Resistance Level
$51.66
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
26.44
Wall Street Target
$56.00
(+15.9%)
Revenue Growth (YoY)
27.0%
Earnings Growth (YoY)
-99.4%
Profit Margin
4.0%
Valuation Premium vs History
+6.6% premium
PE vs Historical
26.4 vs 21.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.6%
(market-implied from PE analysis)
1-Year Target
$51.52
(+7%)
2-Year Target
$54.92
(+14%)
3-Year Target
$58.54
(+21%)
3-Yr Target (if PE normalizes)
(PE: 26→22)
PE COMPRESSION
$48.28
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 26.4, Growth: 43.4%)
$142.55
(+195%)
Base:
(SPY PE: 20.1, Growth: 43.4%)
$108.22
(+124%)
Bear:
(PE: 17.1, Growth: 43.4%)
$91.99
(+90%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (133x PE), but valuation improves significantly next year (26x PE) as earnings recover.
Forward PE: 133.33 | Forward EPS (Implied): $0.36
Bull Case
$58.36
(+21%)
Analyst growth 15.0%, PE expands to 140.0
Base Case
$48.33
(0%)
Market implied 0.0%, PE stable at 133.3
Bear Case
$36.97
(-24%)
Severe decline -15.0%, PE contracts to 120.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 23, 2026 3:51 PM ET
Data refreshes hourly during market hours. Next update: 4:51 PM
Data refreshes hourly during market hours. Next update: 4:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALKS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
David Joseph Gaffin
SELL
2034 shares
2026-04-06
Craig C Hopkinson
SELL
9000 shares
2026-04-01
Christian Todd Nichols
SELL
6000 shares
2026-03-02
Featured in Portfolios
ALKS is a key holding in these high-performance investment strategies.
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$212 | 67 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$107 | 56 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$101 | 43 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$664 | 48 HOLD |
|
LQDA
Liquidia Technologies Inc |
STRONG BUY
10 analysts |
$108 | 55 HOLD |
Advanced ALKS Option Strategies
Professional options setups generated by AI based on today's ALKS price and gamma walls.
